Nikon Corporation announced today that it signed an agreement to invest in Retina Institute Japan, K.K. (RIJ).
Under the agreement, Nikon will subscribe for 500 million yen worth of shares issued by RIJ.
Together, Nikon and RIJ will collaborate on developing practical uses of medical treatments for age-related macular degeneration. RIJ has been working on the world's first case of regenerative medicine using iPS cell technology, utilizing Nikon's own core technology in optics and imaging.